- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$7.48 BnMarket Estimate, 2026
$7.94 BnMarket Forecast, 2034
$12.85 BnCAGR, 2026–2034
6.2%Executive Summary: Europe Lung Cancer Surgery Market
- Market Scope: Comprehensive regional analysis of the European lung cancer surgery market covering surgical procedures, medical device categories, country-level insights, and advanced minimally invasive adoption trends.
- Market Valuation: Valued at USD 7.48 billion in 2025, estimated at USD 7.94 billion in 2026, and projected to reach USD 12.85 billion by 2034, registering a steady CAGR of 6.2% from 2026 to 2034.
- Primary Growth Drivers: Rising pollution levels and growing cigarette smoking rates; increasing incidence and prevalence of lung cancer; and expanding aging population bases coupled with advanced healthcare infrastructure.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment / Position | Fastest-Growing Segment / Breakdown |
|---|---|---|
| By Procedure | Thoracotomy (Lobectomy, Pneumonectomy, Sleeve Resection, Segmentectomy) & Minimally Invasive | Minimally invasive surgeries are expected to grow at the highest CAGR due to early detection awareness and clinical benefits over conventional open procedures. |
| By Device | Surgical Instruments (Clamps, Forceps, Retractors, Staplers, etc.) & Monitoring/Visualizing Systems | Surgical instruments dominate the market driven by shorter device lifespans and widespread adoption across clinical facilities. |
| By Country / Region | Europe (Second-largest global market after North America) | Anchored by advanced healthcare facilities, high awareness, and economic stability. Country coverage includes UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe. |
Major Market Players & Market Structure
Market Structure: Highly competitive medical technology ecosystem driven by leading global surgical device and robotic-assisted system manufacturers.
Key Companies: Ethicon US, LLC, Intuitive Surgical, Inc., AngioDynamics, Inc., Olympus Corporation, Accuray Incorporated, Ackermann Instrumente GmbH, Teleflex Incorporated, KARL STORZ SE & Co. KG, Scanlan International, Inc., and Trokamed GmbH.
Europe Lung Cancer Surgery Market Size
The European lung cancer surgery market size was valued at USD 7.48 billion in 2025 and is anticipated to reach USD 7.94 billion in 2026 from USD 12.85 billion by 2034, growing at a CAGR of 6.2% during the forecast period from 2026 to 2034.
Cancer is generally defined by the name of the part in which it starts. Lung Cancer is a Cancer that starts in Bronchus, lung Tissue, or Trachea. They are many ways to treat Lung Cancer like Radiotherapy, Chemotherapy, Laser therapy, and Surgery. Surgery involves the removal of the infected sections from the lungs. But Surgery can only be used if cancer cells don’t spread very near to the heart.
Rising pollution levels, an increasing number of cigarette smokers, rising incidence and prevalence of Lung Cancer, and rising geriatric population are major factors driving the market.
However, the high cost of Lung Cancer surgery is restraining the growth of the market.
Based on procedure, Minimally Invasive surgeries are expected to grow at the highest CAGR owing to the rising awareness among people for early detection of lung cancer and the advantages of Minimally Invasive Surgeries over conventional surgeries.
Based on the device, the Surgical Instruments segment is expected to dominate the market due to the shorter lifespan of devices and the wider adoption of these devices.
Geographically, Europe has the second-largest market after North America owing to its Advanced Healthcare facilities and higher awareness among people, and greater economic stability.
KEY MARKET PLAYERS
Promising companies leading the European Lung Cancer Surgery Market include
- Ethicon US, LLC
- Intuitive Surgical, Inc.
- AngioDynamics, Inc.
- Olympus Corporation
- Accuray Incorporated
- Ackermann Instrumente GmbH
- Teleflex Incorporated
- KARL STORZ SE & Co. KG
- Scanlan International, Inc.
- Trokamed GmbH
MARKET SEGMENTATION
This research report on the European Lung Cancer Surgery Market has been segmented & sub-segmented into the following categories:
By Procedure
- Thoracotomy
- Lobectomy
- Pneumonectomy
- Sleeve Resection
- Segmentectomy
- Minimally Invasive
By Device
- Surgical
- Clamps
- Forceps
- Retractors
- Staplers
- Cutters
- Scissors
- Elevators
- RIB Sheers
- Trocars
- Monitoring
- Cameras
- Video Support
- Visualizing Systems
- Endoscopic Trocars with Optical Views
- Endo Surgical Equipment
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe